Nabriva Therapeutics AG ADR | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
Cash & Short Term Investments
3,594.00
1,770.00
111,440.50
84,347.40
Total Accounts Receivable
966.00
1,422.00
4,195.00
5,591.70
Other Current Assets
89.00
121.00
610.00
1,182.50
Total Current Assets
4,649.00
3,313.00
116,245.50
91,121.70
Net Property, Plant & Equipment
360.00
314.00
417.00
521.90
Total Investments and Advances
295.00
326.00
430.00
422.30
Intangible Assets
20.00
10.00
3.00
271.50
Total Assets
5,324.00
3,963.00
117,711.50
93,755.10
ST Debt & Current Portion LT Debt
11,377.00
19,216.00
-
-
Accounts Payable
377.00
292.00
2,928.00
2,565.10
Income Tax Payable
772.00
831.00
170.00
18.10
Other Current Liabilities
2,470.00
8,533.00
5,823.00
13,381.50
Total Current Liabilities
14,996.00
28,872.00
8,921.00
15,964.70
Long-Term Debt
503.00
2,834.00
-
-
Deferred Taxes
-
9.00
616.00
1,417.80
Other Liabilities
6,655.00
2,407.00
84.00
107.60
Total Liabilities
22,154.00
34,122.00
9,005.00
16,072.30
Common Equity (Total)
16,830.00
30,159.00
108,706.50
77,682.80
Total Shareholders' Equity
16,830.00
30,159.00
108,706.50
77,682.80
Total Equity
16,830.00
30,159.00
108,706.50
77,682.80
Liabilities & Shareholders' Equity
5,324.00
3,963.00
117,711.50
93,755.10
About Nabriva Therapeutics
View Profile
